BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22239207)

  • 1. Red blood cell alloimmunization in sickle cell anemia: more questions than answers?
    Campbell-Lee SA
    Transfusion; 2012 Feb; 52(2):214-6. PubMed ID: 22239207
    [No Abstract]   [Full Text] [Related]  

  • 2. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of red blood cell alloimmunization risk reduction.
    Karafin MS; Denomme GA; Bryant BJ
    Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoregulatory networks in sickle cell alloimmunization.
    Yazdanbakhsh K
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):457-461. PubMed ID: 27913516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of alloimmunization in patients with haemoglobinopathies.
    Chou ST; Liem RI; Thompson AA
    Br J Haematol; 2012 Nov; 159(4):394-404. PubMed ID: 23034087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.
    Allali S; Peyrard T; Amiranoff D; Cohen JF; Chalumeau M; Brousse V; de Montalembert M
    Br J Haematol; 2017 May; 177(4):641-647. PubMed ID: 28402005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of sickle cell alloimmunization.
    Yazdanbakhsh K
    Transfus Clin Biol; 2015 Aug; 22(3):178-81. PubMed ID: 26056038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of red blood cell alloimmunization risk reduction.
    Kacker S; Ness PM; Shirey RS; Savage WJ; King KE; Tobian AA
    Transfusion; 2015 Jan; 55(1):222-4. PubMed ID: 25582240
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 12. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For the patient. Alloimmunization: one risk of treating sickle cell disease.
    Ethn Dis; 2010; 20(2):195. PubMed ID: 20506598
    [No Abstract]   [Full Text] [Related]  

  • 14. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for alloimmunization in patients with sickle cell anemia.
    Pinto PC; Braga JA; Santos AM
    Rev Assoc Med Bras (1992); 2011; 57(6):668-73. PubMed ID: 22249547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alloimmunization in poly-transfused patients with hemoglobin S disease].
    Gómez Oliva P; Basanta Otero P; González Villalonga C; Batista Veranes M; Orbeal Aldama L; García Echevarría M
    Sangre (Barc); 1985; 30(4-A):406-10. PubMed ID: 4071354
    [No Abstract]   [Full Text] [Related]  

  • 18. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
    Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
    Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
    Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
    Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
    Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
    Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.